Summary
Latest filing:
Rahsaan Thompson is Chief Legal & Compliance of ZEVRA THERAPEUTICS, INC. (ZVRA). 4 SEC Form 4 filings on record, most recently on 17 August 2026. Most recent open-market trade: sold $475K of ZVRA on 17 August 2026. Lifetime open-market sales: $969K.
Recent Transactions
6Every recent SEC Form 4 transaction Rahsaan Thompson has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Rahsaan Thompson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil F. McFarlane - $1.19M of ZVRA open-market activity in the last 12 months
- Corey Michael Watton - $138K of ZVRA open-market activity in the last 12 months
- Joshua Schafer - $126K of ZVRA open-market activity in the last 12 months
- Timothy J. Sangiovanni - $43K of ZVRA open-market activity in the last 12 months
- Adrian W. Quartel - $40K of ZVRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Rahsaan Thompson?
Rahsaan Thompson is a corporate insider, tracked as Chief Legal & Compliance of ZEVRA THERAPEUTICS, INC. (ZVRA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Rahsaan Thompson submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Rahsaan Thompson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($969K) across all tracked filings.
Where can I see all of Rahsaan Thompson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Rahsaan Thompson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
